Angiotensin-converting enzyme inhibitors and stroke

Blood pressure reduction is major determinant of risk

Mori J. Krantz, Daniel E. Hilleman, B. Daniel Lucas

Research output: Contribution to journalShort survey

Original languageEnglish
Pages (from-to)1813-1814
Number of pages2
JournalPharmacotherapy
Volume24
Issue number12 I
DOIs
StatePublished - Dec 2004

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Angiotensin-converting enzyme inhibitors and stroke : Blood pressure reduction is major determinant of risk. / Krantz, Mori J.; Hilleman, Daniel E.; Lucas, B. Daniel.

In: Pharmacotherapy, Vol. 24, No. 12 I, 12.2004, p. 1813-1814.

Research output: Contribution to journalShort survey

@article{36052371dba4440eb73261019bc31a48,
title = "Angiotensin-converting enzyme inhibitors and stroke: Blood pressure reduction is major determinant of risk",
author = "Krantz, {Mori J.} and Hilleman, {Daniel E.} and Lucas, {B. Daniel}",
year = "2004",
month = "12",
doi = "10.1592/phco.24.17.1813.52343",
language = "English",
volume = "24",
pages = "1813--1814",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "12 I",

}

TY - JOUR

T1 - Angiotensin-converting enzyme inhibitors and stroke

T2 - Blood pressure reduction is major determinant of risk

AU - Krantz, Mori J.

AU - Hilleman, Daniel E.

AU - Lucas, B. Daniel

PY - 2004/12

Y1 - 2004/12

UR - http://www.scopus.com/inward/record.url?scp=9644278027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644278027&partnerID=8YFLogxK

U2 - 10.1592/phco.24.17.1813.52343

DO - 10.1592/phco.24.17.1813.52343

M3 - Short survey

VL - 24

SP - 1813

EP - 1814

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 12 I

ER -